Amygdala Neurons In Dementia With Lewy Bodies is a cell type relevant to neurodegenerative disease research. This page covers its role in brain function, involvement in disease processes, and significance for therapeutic strategies.
The amygdala is particularly vulnerable in Dementia with Lewy Bodies (DLB), exhibiting Lewy body pathology that significantly impacts emotional processing, memory encoding, and autonomic function. The amygdala's extensive connections with the basal forebrain, hippocampus, and brainstem nuclei make it a critical hub for understanding DLB pathogenesis.
In DLB, the amygdala demonstrates:
Amygdala dysfunction in DLB contributes to:
The central nucleus of the amygdala projects to autonomic centers, contributing to:
| Neurotransmitter | Change | Impact |
|---|---|---|
| GABA | ↓↓ | Anxiety, seizure susceptibility |
| Glutamate | ↓ | Cognitive impairment |
| Serotonin | ↓ | Depression, mood disorders |
| Norepinephrine | ↓↓ | Autonomic dysfunction |
The study of Amygdala Neurons In Dementia With Lewy Bodies has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Tsuang, D., et al. (2012). Neuropathology of the Amygdala in Lewy Body Disease. Acta Neuropathologica.
[2] Yoshida, M., et al. (2020). Amygdala Pathology in Dementia with Lewy Bodies. Journal of Neuropathology & Experimental Neurology.
[3] Beach, T.G., et al. (2009).Organization of the Amygdala in Dementia with Lewy Bodies. Journal of Neuropathology & Experimental Neurology.
[4] Fujishiro, H., et al. (2008). Distribution of Amygdala-Lewy Bodies in Parkinson's Disease and Dementia with Lewy Bodies. Acta Neuropathologica.
[5] Halliday, G.M., et al. (2014). Neuropathology of the Amygdala in Lewy Body Disorders. Handbook of Clinical Neurology.